Australia approved the anti-viral drug remdesivir for treatment of COVID-19 Friday following a similar decision from the European Commission.
It is the first drug approved by Australian authorities to treat the virus and promised to reduce hospitalisation time for coronavirus patients, Australia’s Therapeutic Goods Administration(TGA) said in a statement.
“ By reducing recovery times, patients will be able to leave hospital earlier, freeing beds for those in need,” the TGA said.
The drug was given provisional approval for adults and adolescent patients and would be limited to those severely unwell from the virus, needing help to breathe and in hospital care, the authority noted.